Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

Delayed Data
As of Oct 21
 +0.42 / +8.20%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Merrimack Pharmaceuticals Inc have a median target of 10.00, with a high estimate of 15.00 and a low estimate of 7.00. The median estimate represents a +80.51% increase from the last price of 5.54.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Hold stock in Merrimack Pharmaceuticals Inc. This rating has held steady since October, when it was downgraded from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 33.13%
Growthannually 18.61%


Growthquarterly -16.43%
Growthannually 96.68%
Key to the earnings and sales forecast charts.